A complex of MET, CD44 variant 6 and the MET ligand HGF has been identified in the colorectal cancer cell line HT-29 and has been demonstrated as being essential for MET activation (Orian-Rousseau et al. 2002). The gene discussed is HGF; the disease is colorectal cancer.